A PYMNTS Company

US: DOJ urges SCOTUS to hear case against Chinese vitamin cartel

By  |  November 19, 2017

Lawyers at the US Justice Department defied China’s Ministry of Commerce in a brief urging the US Supreme Court to review the dismissal of an antitrust class action against a cartel of Chinese vitamin manufacturers, reported Reuters.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The brief, filed by the US Solicitor General and the Justice Department’s antitrust chief, argues that the 2nd US Circuit Court of Appeals paid too much deference to the Chinese ministry’s characterization of Chinese antitrust law.

    The US government recommended the Supreme Court hear the case, Animal Science Products v. Hebei Welcome Pharmaceutical, to clarify how much weight US courts should give to foreign sovereigns’ descriptions of their laws.

    The respondents are Chinese manufacturers and exporters of Vitamin C that have been accused of anti-competitive behavior in violation of the Sherman Act. The companies do not contest these allegations but argue that they were compelled to act by Chinese laws and regulations.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.